Relay Therapeutics, Inc. (RLAY)
18.96
+0.47
(+2.54%)
USD |
NASDAQ |
Oct 02, 16:00
18.63
-0.33
(-1.74%)
After-Hours: 20:00
Relay Therapeutics EPS Diluted (Quarterly) : -0.4127 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4127 |
| March 31, 2026 | -0.4075 |
| December 31, 2025 | -0.3165 |
| September 30, 2025 | -0.4301 |
| June 30, 2025 | -0.4109 |
| March 31, 2025 | -0.4554 |
| December 31, 2024 | -0.4542 |
| September 30, 2024 | -0.6283 |
| June 30, 2024 | -0.6942 |
| March 31, 2024 | -0.622 |
| December 31, 2023 | -0.6693 |
| September 30, 2023 | -0.5378 |
| June 30, 2023 | -0.8095 |
| March 31, 2023 | -0.7768 |
| December 31, 2022 | -0.558 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.759 |
| June 30, 2022 | -0.7068 |
| March 31, 2022 | -0.5729 |
| December 31, 2021 | -0.6237 |
| September 30, 2021 | -0.6563 |
| June 30, 2021 | -2.104 |
| March 31, 2021 | -0.4677 |
| December 31, 2020 | 0.3924 |
| September 30, 2020 | -2.382 |
| June 30, 2020 | -0.297 |
| March 31, 2020 | -0.2769 |
| December 31, 2019 | -0.2661 |
| September 30, 2019 | -0.2189 |
| June 30, 2019 | -0.1949 |
| March 31, 2019 | -0.1578 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.0508 |
| Karyopharm Therapeutics, Inc. | -2.316 |
| Spyre Therapeutics, Inc. | -0.4272 |
| Akebia Therapeutics, Inc. | -0.033 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -83.71M |
| Revenue (Quarterly) | 0.35M |
| Total Expenses (Quarterly) | 84.06M |
| Enterprise Value | 3.263B |
| Gross Profit Margin (Quarterly) | -2.86% |
| Profit Margin (Quarterly) | -23.92K% |
| Earnings Yield | -8.26% |
| Normalized Earnings Yield | -8.264 |